Now in press @JCardFail, during incremental ramp exercise, addition of 10+ upright invasive exercise hemodynamic measures is feasible with nearly identical peak RER, workload and VO2 to non-invasive CPET https://t.co/OnOcTQ2Iwi More to come @ChiHForum
I’m truly delighted to be attending the outstanding master class course in Heart Failure here in Baku. Happy to be part of this educational event. #heartfailure#zurichhearthouse#londonhearthouse
Supporting recommendations from the latest guideline on #cvACS, #CardioSmart’s new infographic 👇 shares the benefits of participating in a cardiac rehabilitation program, what these programs entail and where patients can access care.
Learn more: https://t.co/uARrWloOI6 #cvRehab
#EAPC25#ESCPrev25 Three incredible days in Milan! Thank you all for the amazing and insightful presentations. Special thanks to all the speakers and organizers. It was a true honor and privilege to be among the stars of cardiology.
#ESCPrev2025 My first congress! Can’t believe this long-awaited day is finally here. Excited and looking forward to the most interesting and relevant topics!
New 👀insights from the International #Takotsubo (InterTAK) registry!
⬆️ prevalence in ♂️, ⬆️ recognition of midventricular TTS type, & ⬆️ short-term mortality & rates of 🫀 shock in recent years https://t.co/aOPxnUZ4NO
#ESCCongress#JACC
Must-read statement for the European Association of Preventive Cardiology (EAPC) on The future of education in Preventive Cardiology https://t.co/1lOwSlMWS8 @EAPCPresident
Cardiac rehabilitation provides evidence-based, secondary prevention after a cardiovascular event. A new Review Article addresses the benefits of cardiac rehabilitation programs and current barriers to participation. Read the full review: https://t.co/RrrzlJ6x22
⚠️Cardiac and Metabolic Effects of Dapagliflozin in HFpEF #CAMEO-DAPA Trial
👥38HFpEF+ elevated PCWP during exercise
🎯 change from baseline in rest and peak exercise PCWPs
👉dapagliflozin:
📌⤵️change in PCWP at rest and during exercise at 24 weeks vs placebo 📌⤵️Body weight & plasma volume
📌🚫no effect on red blood cell volume
📌🚫no differences in oxygen consumption at 20-W or peak exercise, 📌⤵️ decreased arterial lactate at 20 W
📥 https://t.co/oMKbKW3oCl @CircHF@Dr_Manito
Soviet water polo player Petre Kako Mshvenieradze was captured in a heartwarming moment with his grandson in 1990. A legendary athlete, he had a remarkable career representing the Soviet Union in multiple Summer Olympics.
1. 1952 Summer Olympics: Petre Kako Mshvenieradze showcased his skills and dedication to the sport as he competed in water polo at the 1952 Helsinki Summer Olympics. The tournament was a testament to his talent and commitment to the team.
2. 1956 Summer Olympics: Four years later, at the 1956 Melbourne Summer Olympics, Petre Kako Mshvenieradze's exceptional performance led the Soviet water polo team to a historic victory. They secured the bronze medal, demonstrating their prowess and competitiveness on the international stage.
3. 1960 Summer Olympics: Undeterred by the previous achievements, Petre Kako Mshvenieradze continued to shine in the water polo world. At the 1960 Rome Summer Olympics, his unparalleled skills and leadership guided the Soviet Union to an even greater accomplishment - winning the silver medal. This achievement solidified his reputation as one of the finest water polo players of his time.
Throughout his career, Petre Kako Mshvenieradze's contributions to the sport of water polo left an indelible mark, inspiring future generations of athletes. His dedication and passion for the game served as an example of sportsmanship and excellence both on and off the field.
Breaking news: FDA has just approved sotagliflozin (brand name "Inpefa") for Treatment of Heart Failure!!!!
Broad label across full LVEF range (HFpEF&HFrEF), and for patients with or without T2DM
First dual SGLT1/2 inhibitor to be approved in HF
@DLBHATTMD@ChristosArgyrop